Deramo Paul, Martinez Carlos A, Boutros Sean G
The University of Texas Health Science Center at Houston, Houston, Tex.
Houston Plastic Craniofacial and Sinus Surgery, Houston, Tex.
Plast Reconstr Surg Glob Open. 2020 Jul 15;8(7):e2978. doi: 10.1097/GOX.0000000000002978. eCollection 2020 Jul.
Breast reconstruction with autologous tissue following mastectomy for breast cancer has become the standard of care. Microvascular breast augmentation is an alternative for patients with failed breast prostheses, including painful capsular contractures or poor cosmetic outcomes. We present a series of 4 patients who underwent microvascular breast augmentation with cross-chest flap recipient vessels.
We perform a bilateral DIEP flap reconstruction in an outpatient setting following a modified recovery protocol, focused on decreasing postoperative pain and narcotic requirements, allowing early ambulation and discharge. This includes harvest of the flap via abdominal microfascial incisions and rib-sparing vessel dissection. Cosmetic microvascular augmentation of the contralateral breast was performed via cross-chest flap recipient vessel anastomoses, where the pedicle was tunneled across the chest and anastomosed to the primary flap.
Four patients underwent flap-based breast augmentation with cross-chest recipient vessels. Two patients underwent immediate DIEP flap breast reconstruction of the affected side and contralateral flap-based augmentation, while 2 patients underwent bilateral breast augmentation with DIEP flaps for cosmetic purposes due to undesired cosmetic results following implant-based augmentations. No intraoperative complications were reported, and all patients were discharged within 23 hours without signs of flap compromise or need for operative take-backs. Mean follow-up was 23 weeks.
The DIEP flap is recognized as an option for breast augmentation, although its limitations are several, including the pain and recovery associated with autologous tissue-based breast reconstruction. Enhanced recovery protocols help reduce this burden, making it more acceptable and feasible.
乳腺癌乳房切除术后采用自体组织进行乳房重建已成为护理标准。微血管乳房增大术是乳房假体植入失败患者的一种选择,包括疼痛性包膜挛缩或美容效果不佳。我们报告了一系列4例采用跨胸皮瓣受区血管进行微血管乳房增大术的患者。
我们在门诊环境中按照改良的恢复方案进行双侧腹壁下动脉穿支皮瓣重建,重点是减轻术后疼痛和减少麻醉药物需求,以便早期下床活动和出院。这包括通过腹部微筋膜切口切取皮瓣和保留肋骨的血管解剖。通过跨胸皮瓣受区血管吻合对侧乳房进行美容性微血管增大术,将蒂部经胸部隧道穿过并与主要皮瓣吻合。
4例患者采用跨胸受区血管进行基于皮瓣的乳房增大术。2例患者对患侧进行即刻腹壁下动脉穿支皮瓣乳房重建并对侧进行基于皮瓣的增大术,而2例患者因基于植入物的增大术后美容效果不理想,出于美容目的采用腹壁下动脉穿支皮瓣进行双侧乳房增大术。未报告术中并发症,所有患者均在23小时内出院,无皮瓣受损迹象或需要再次手术。平均随访23周。
腹壁下动脉穿支皮瓣被认为是乳房增大术的一种选择,尽管其有一些局限性,包括与自体组织乳房重建相关的疼痛和恢复问题。强化恢复方案有助于减轻这种负担,使其更易于接受和可行。